Industry News
Gene variant linked to smoking longer, getting lung cancer sooner
4/16/2015
Smokers with a specific genetic variation are more likely to keep smoking longer than those who don't have the gene variant, new research indicates.
Potential for prediction of progression for early form of breast cancer
4/16/2015
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Researchers discover an inactive tumor suppressor gene in lung cancer
4/16/2015
Inactivation of PARD3 gene promotes tumor cell invasion and metastasisCorrect tight junctions between cells labeled in yellow due to the presence of the protein PARD3.
High fidelity: SLU researcher finds keys to genome integrity
4/16/2015
Four-way junctions hold answers to clearing DNA replication road blocksMaintaining the stability and the correct sequence of our genetic information is vital to the accurate transmission of our...
Genetically engineered Salmonella promising as anti-cancer therapy
4/16/2015
A new study has demonstrated that genetically modified Salmonella can be used to kill cancer cells.
CNIO experts identify an oncogene regulated by nutrients
4/16/2015
Scientists from the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Center (CNIO), led by Nabil Djouder, have discovered that the MCRS1 protein, in response to an...
The cost and quality of cancer care in Health Affairs' April issue
4/16/2015
1. Cancer Mortality Reductions Were Greatest Among Countries Where Cancer Care Spending Rose The Most, 1995-2007.Warren Stevens of Precision Health Economics, Dana P.
Immunotherapy fights cancer better with both arms of the immune system, say researchers
4/15/2015
The idea of fighting cancer with immunotherapy is to trigger the immune system. Now, a new study suggests recruiting both the innate and the adaptive immune system works best.
Melanoma's 'safe haven' targeted for shut-down
4/15/2015
Melanoma cells become drug resistant by using surrounding healthy cells to provide a 'safe haven' from treatment, according to new research published in Cancer Cell.
Vargatef (nintedanib) in combination with docetaxel accepted for use within NHS Scotland
4/15/2015
Boehringer Ingelheim Limited are delighted that the Scottish Medicines Consortium (SMC), following a full submission under the end of life and orphan equivalent process has accepted nintedanib...